<DOC>
	<DOCNO>NCT02540759</DOCNO>
	<brief_summary>The effect various dos Buglossoides oil accrual eicosapentaenoic acid ( EPA ) blood circulate cell investigate .</brief_summary>
	<brief_title>Effect Dose Buglossoides Oil EPA Accrual Inflammatory Response</brief_title>
	<detailed_description />
	<criteria>1 . Men nonpregnant woman , use effective form birth control ( oral contraceptive , injectable contraceptive barrier method intrauterine device ( IUD ) spermicide , diaphragm spermicide , condom spermicide sponge spermicide ) least 3 month prior entry study continue participation study . 2 . 18 65 year age , inclusive . 3 . Body mass index ( BMI ) 18 39.9 kg/m2 4 . Subject willing avoid alcohol consumption 24h prior every clinic visit . 5 . The subject modify smoking habit supplementation period . 6 . No significant medical condition opinion qualify physician , would preclude subject 's participation study . 7 . Signed informed consent . 8 . Willing follow study procedure include study visit , fast blood draw , stable body weight , normal eat habit , current activity level , compliance study preparation . 9 . Willing consume fish , crustaceans shellfish duration study . 1 . Pregnancy lactation . Women try conceive . Women try conceive unwilling commit use medically approve form contraception throughout study period . Method contraception must record case report file . 2 . Individual condition study physician believe would interfere participant 's ability provide inform consent , comply responsibility study , might confound interpretation study result put person undue risk . 3 . Medical condition include active peptic ulcer , inflammatory bowel disease , gastrointestinal bleeding medical condition prior gastrointestinal surgery could influence absorption , metabolism excretion study supplement . 4 . History presence significant , renal , hepatic , gastrointestinal , pulmonary , biliary , neurological endocrine disorder . 5 . History presence cancer past 2 yr , except nonmelanoma skin cancer ( e.g . basal squamous cell carcinoma skin ) . 6 . Clinically significant abnormal laboratory test result include limited LDLcholesterol ≥ 4.1mM , triglyceride level ≥3.95mM , fast creatinine ≥ 1.5 mg/dL , alanine transaminase aspartate aminotransferase ≥ 1.5X upper limit normal . 7 . Currently treat angina , arrhythmia and/or congestive heart failure . History myocardial infarction stroke . 8 . Uncontrolled hypertension ( rest systolic blood pressure ≥ 160 mmHg diastolic blood pressure ≥ 100 mmHg ) . 9 . Type 1 2 diabetes . Fasting glucose ≥ 100 mg/dL . HbA1c ≥ 6.0 . 10 . If smoker , subject smoke 1 pack ( 20 cigarette ) daily . 11 . History ( within 12 month ) current alcohol substance abuse ( 14 consumption per week ; 1 consumption= 12 oz beer , 5 oz wine , 1.5 oz distil spirit ) . 12 . Use lipidaltering medication ( statin , bile acid sequestrants , cholesterol absorption inhibitor , fibrates , counter prescription formulation niacin ) . 13 . Unstable use thyroid medication . Stable , treated hypothyroidism exclusion criterion . 14 . Use weight loss lipid metabolism medication/supplement/program ( include lipase inhibitor ) within 1 month study period OR weight gain loss &gt; 2 kg past 3 month . 15 . Currently take fish oil omega3 omega6 polyunsaturated fatty acid ( PUFA ) supplement/drug within one month Visit 1 throughout study . Consumption fatty fish ( salmon , herring , mackerel , albacore tuna , sardine ) 2X month within one month visit 1 throughout study period . Consumption ( twice month ) EPA/DHA enrich food ( e.g . docosahexaenoic acid ( DHA ) enrich egg ) within one month Visit 1 . Unwillingness avoid fish include shellfish crustacean throughout study period . 16 . Use alphalinolenic acidcontaining seed oil flax seed , chia seed , perilla seed , hemp , spirulina , walnut , mustard seed black currant seeds/oil within one month Visit 1 throughout study . 17 . Use investigational product within previous 30 day . 18 . Has donate blood 4 week start study . Not willing cease blood donor study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Buglossoides arvensis</keyword>
	<keyword>vegetable oil</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>participant</keyword>
</DOC>